Extracellular matrix and its therapeutic potential for cancer treatment
J Huang, L Zhang, D Wan, L Zhou, S Zheng… - … and Targeted Therapy, 2021 - nature.com
The extracellular matrix (ECM) is one of the major components of tumors that plays multiple
crucial roles, including mechanical support, modulation of the microenvironment, and a …
crucial roles, including mechanical support, modulation of the microenvironment, and a …
Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment
H Harjunpää, M Llort Asens, C Guenther… - Frontiers in …, 2019 - frontiersin.org
The immune system and cancer have a complex relationship with the immune system
playing a dual role in tumor development. The effector cells of the immune system can …
playing a dual role in tumor development. The effector cells of the immune system can …
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
JJF Sleeboom, GS van Tienderen… - Science translational …, 2024 - science.org
The extracellular matrix (ECM) is essential for cell support during homeostasis and plays a
critical role in cancer. Although research often concentrates on the tumor's cellular aspect …
critical role in cancer. Although research often concentrates on the tumor's cellular aspect …
Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM)
Simple Summary Glioblastoma multiforme is one of the hardest-to-treat brain tumors, often
resistant to conventional treatments such as chemotherapy and radiation therapy. Despite …
resistant to conventional treatments such as chemotherapy and radiation therapy. Despite …
[HTML][HTML] Integrins in cancer: Emerging mechanisms and therapeutic opportunities
F Liu, Q Wu, Z Dong, K Liu - Pharmacology & therapeutics, 2023 - Elsevier
Integrins are vital surface adhesion receptors that mediate interactions between the
extracellular matrix (ECM) and cells and are essential for cell migration and the …
extracellular matrix (ECM) and cells and are essential for cell migration and the …
The force awakens: metastatic dormant cancer cells
SY Park, JS Nam - Experimental & Molecular Medicine, 2020 - nature.com
Recurrent cancer that spreads to distant sites is the leading cause of disease-related death
among cancer patients. Cancer cells are likely to disseminate during cancer progression …
among cancer patients. Cancer cells are likely to disseminate during cancer progression …
[HTML][HTML] Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
E Schoutrop, L Moyano-Galceran, S Lheureux… - Seminars in cancer …, 2022 - Elsevier
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the
ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the …
ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the …
Nutrient scavenging in cancer
BT Finicle, V Jayashankar, AL Edinger - Nature Reviews Cancer, 2018 - nature.com
While cancer cell proliferation depends on access to extracellular nutrients, inadequate
tumour perfusion means that glucose, amino acids and lipids are often in short supply. To …
tumour perfusion means that glucose, amino acids and lipids are often in short supply. To …
Are integrins still practicable targets for anti-cancer therapy?
B Alday-Parejo, R Stupp, C Rüegg - Cancers, 2019 - mdpi.com
Correlative clinical evidence and experimental observations indicate that integrin adhesion
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer
Q Gao, Z Yang, S Xu, X Li, X Yang, P **… - Journal of Experimental …, 2019 - rupress.org
High-grade serous ovarian cancer (HGSOC) is hallmarked by early onset of peritoneal
dissemination, which distinguishes it from low-grade serous ovarian cancer (LGSOC). Here …
dissemination, which distinguishes it from low-grade serous ovarian cancer (LGSOC). Here …